組織工学市場：製品、用途、エンドユーザー別-2025-2030年の世界予測

組織工学市場は、2023年に431億3,000万米ドルと評価され、2024年には512億1,000万米ドルに達すると予測され、CAGR 18.82％で成長し、2030年には1,442億8,000万米ドルに達すると予測されています。

組織工学は、損傷した組織や臓器の機能的代替品を開発するために、生物学、工学、臨床科学の原理を活用する学際的な分野です。従来の移植に代わる代替医療を提供することで、ドナー臓器の不足に対処し、ヘルスケアの重要な課題を解決することを目指しています。その範囲には、再生医療、疾患モデリング、薬物検査、体外診断への応用が含まれます。主要な最終用途分野はヘルスケア産業で、特に整形外科、神経学、心臓血管治療です。市場成長の主な原動力は、慢性疾患の有病率の上昇と老人人口の増加です。高度な3Dバイオプリンティング技術、生体材料の研究開発、幹細胞研究などの技術革新が大きな影響力を持っています。さらに、政府による研究支援や研究資金の増加もプラスに働いています。この分野は、特に個別化医療と臓器再生において、大きなビジネスチャンスをもたらしています。こうした機会を活用するため、企業は幹細胞応用の開拓や革新的な足場技術の開発に注力することができます。有望な市場であるにもかかわらず、開発コストの高さ、規制のハードル、幹細胞利用をめぐる倫理的懸念など、いくつかの課題に直面しています。また、複雑な組織構造を複製する際の技術的な制約から生じる限界もあります。成長を目指す企業は、バイオファブリケーションや、より洗練されたin vitro組織モデルの作成といった分野に注力すべきです。組織工学市場の性質は、非常に革新的で急速に進化しており、現在の限界を克服することを目的とした絶え間ない研究開発活動が特徴です。企業は、技術的進歩や規制の変化を常に把握しながら、戦略的パートナーシップを築き、イノベーションを推進するための包括的な研究開発に投資しなければならないです。全体として、この分野には大きな可能性が秘められているが、持続可能な商業的成功を達成するためには、既存の課題を慎重に乗り越える必要があります。

市場力学：急速に進化する組織工学市場の主要市場インサイトを公開

組織工学市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 組織の不可逆的損傷の治療における組織工学処置の潜在的ニーズ
  • 腎臓疾患や生活習慣病の増加に伴う効果的な再生治療の必要性
  • 高度な組織工学用途での生物由来ナノ粒子の使用の増加
• 市場抑制要因
  • 適切な生体材料と適切な生理学的構造を捕捉する技術の不足
• 市場機会
  • 3D組織工学分野における技術の進歩
  • 組織工学研究プロジェクトに対する政府支援の急増
• 市場の課題
  • 組織工学に関連する政府の厳しい規制

ポーターの5つの力：組織工学市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、組織工学市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：組織工学市場における外部からの影響の把握

外部マクロ環境要因は、組織工学市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析組織工学市場における競合情勢の把握

組織工学市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス組織工学市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、組織工学市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨組織工学市場における成功への道筋を描く

組織工学市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 組織の不可逆的な損傷を治療するための組織工学手順の潜在的な必要性
    • 腎臓疾患や生活習慣病の増加による効果的な再生治療の必要性
    • 高度な組織工学アプリケーションにおける生体ナノ粒子の使用の増加
  • 抑制要因
    • 適切な生理学的構造を捉えるための適切な生体材料と技術の欠如
  • 機会
    • 3D分野における技術の進歩組織工学
    • 組織工学調査プロジェクトに対する政府の支援の急増
  • 課題
    • 組織工学に関連する厳格な政府規制
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 組織工学市場：製品別

• 生体材料
  • セルソース
  • 成長因子と生理活性分子
  • 足場材料
    • 複合足場材料
    • ナノ足場材料
    • 天然生物足場材料
    • 合成生分解性ポリマー足場材料
• 装置
  • バイオリアクター
  • 細胞培養チャンバー
  • イメージング＆フローサイトメーター
• サービス

第7章 組織工学市場：用途別

• 心臓血管アプリケーション
• 歯科および頭蓋顔面外科用途
• 医薬品の試験と開発
• 整形外科用途
• 再生医療
• 傷の治癒

第8章 組織工学市場：エンドユーザー別

• 学術機関および政府調査機関
• バイオテクノロジーおよび製薬会社
• 契約調査機関

第9章 南北アメリカの組織工学市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の組織工学市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの組織工学市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 3D BioFibRは、2つのCollaFibR組織工学製品の発売により、バイオプリンティングおよび3D細胞培養市場に参入します。
  • エッセント・バイオロジクス、革新的なヒト天然組織由来I型コラーゲンを発売
  • BioMed XがAbbVieと免疫学および組織工学に関する調査協力を拡大
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Aspect Biosystems Ltd.
• B. Braun SE
• Baxter International Inc.
• Bayer AG
• Becton, Dickinson and Company
• Cook Group Incorporated
• Corning Incorporated
• CTIBiotech
• Frequency Therapeutics
• Gel4Med
• General Electric Company
• Humacyte, Inc.
• Integra LifeSciences Corporation
• Johnson & Johnson Services, Inc.
• Medtronic PLC
• Merck KGaA
• Miromatrix Medical, Inc.
• Modern Meadow
• Novartis AG
• Organogenesis Inc.
• Organovo Holdings, Inc.
• Pfizer Inc.
• Prellis Biologics
• ReproCell Inc.
• Smith & Nephew PLC
• Stryker Corporation
• Tissue Regeneration Systems Inc.
• Vericel Corporation
• Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

• FIGURE 1. TISSUE ENGINEERING MARKET RESEARCH PROCESS
• FIGURE 2. TISSUE ENGINEERING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TISSUE ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. TISSUE ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. TISSUE ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TISSUE ENGINEERING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TISSUE ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TISSUE ENGINEERING MARKET DYNAMICS
• TABLE 7. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY GROWTH FACTORS & BIOACTIVE MOLECULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COMPOSITE SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY NANO-SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY NATURAL BIOLOGICAL SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC BIODEGRADABLE POLYMER SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE CHAMBERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY IMAGE & FLOW CYTOMETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY DENTAL & CRANIOFACIAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY DRUG TESTING & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. CANADA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. CANADA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 56. CANADA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 57. CANADA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 58. CANADA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. CANADA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. CHINA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. CHINA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 88. CHINA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 89. CHINA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 90. CHINA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. CHINA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. INDIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. INDIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 94. INDIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 95. INDIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 96. INDIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. INDIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. JAPAN TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. THAILAND TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. DENMARK TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. EGYPT TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. FINLAND TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. FRANCE TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. GERMANY TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. ITALY TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. ITALY TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 197. ITALY TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 198. ITALY TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 199. ITALY TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. ITALY TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. NORWAY TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 219. POLAND TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 220. POLAND TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 221. POLAND TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 222. POLAND TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 223. POLAND TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. POLAND TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. QATAR TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 226. QATAR TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 227. QATAR TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 228. QATAR TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 229. QATAR TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. QATAR TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 242. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 248. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 254. SPAIN TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 260. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 266. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 272. TURKEY TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 284. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 285. TISSUE ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 286. TISSUE ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023

The Tissue Engineering Market was valued at USD 43.13 billion in 2023, expected to reach USD 51.21 billion in 2024, and is projected to grow at a CAGR of 18.82%, to USD 144.28 billion by 2030.

Tissue engineering is a multidisciplinary field that harnesses principles from biology, engineering, and clinical sciences to develop functional substitutes for damaged tissues and organs. It aims to solve significant healthcare challenges by offering alternatives to traditional transplantations, thereby addressing the shortage of donor organs. The scope includes applications in regenerative medicine, disease modeling, drug testing, and in vitro diagnostics. Key end-use segments are in the healthcare industry, particularly in orthopedics, neurology, and cardiovascular treatments. Market growth is primarily driven by the rising prevalence of chronic diseases and the increasing geriatric population. Technological innovations-such as advanced 3D bioprinting techniques, development of biomaterials, and stem cell research-serve as significant influencers. Furthermore, increasing governmental support and funding for research contribute positively. The field offers substantial opportunities, particularly in personalized medicine and organ regeneration. To capitalize on these opportunities, businesses can focus on pioneering stem cell applications and developing innovative scaffold technologies. Despite its promising prospects, the market faces several challenges, including high development costs, regulatory hurdles, and ethical concerns surrounding stem cell use. Limitations also arise from technological constraints in replicating complex tissue structures. Companies aiming for growth should focus on areas like biofabrication and the creation of more sophisticated in vitro tissue models. The nature of the tissue engineering market is highly innovative and rapidly evolving, characterized by constant research and development activities aimed at overcoming current limitations. Businesses must stay abreast of technological advances and regulatory changes while forging strategic partnerships and investing in comprehensive R&D to drive innovation. Overall, the field holds vast potential, but it requires careful navigation through existing challenges to achieve sustainable commercial success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tissue Engineering Market

The Tissue Engineering Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Potential need for tissue engineering procedures in treating irreversible damage of tissues
  • Need for effective regenerative treatments owing to a rise in kidney and lifestyle related disorders
  • Growing use of biogenic nanoparticles for advanced tissue engineering applications
• Market Restraints
  • Lack of suitable biomaterials and techniques for capturing appropriate physiological architectures
• Market Opportunities
  • Technological advancements in the field of 3D tissue engineering
  • Surging government support for tissue engineering research projects
• Market Challenges
  • Stringent government regulations associated with tissue engineering

Porter's Five Forces: A Strategic Tool for Navigating the Tissue Engineering Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tissue Engineering Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tissue Engineering Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tissue Engineering Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tissue Engineering Market

A detailed market share analysis in the Tissue Engineering Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tissue Engineering Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tissue Engineering Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tissue Engineering Market

A strategic analysis of the Tissue Engineering Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tissue Engineering Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aspect Biosystems Ltd., B. Braun SE, Baxter International Inc., Bayer AG, Becton, Dickinson and Company, Cook Group Incorporated, Corning Incorporated, CTIBiotech, Frequency Therapeutics, Gel4Med, General Electric Company, Humacyte, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Merck KGaA, Miromatrix Medical, Inc., Modern Meadow, Novartis AG, Organogenesis Inc., Organovo Holdings, Inc., Pfizer Inc., Prellis Biologics, ReproCell Inc., Smith & Nephew PLC, Stryker Corporation, Tissue Regeneration Systems Inc., Vericel Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Tissue Engineering Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Biomaterials, Equipment, and Services. The Biomaterials is further studied across Cell Sources, Growth Factors & Bioactive Molecules, and Scaffold Materials. The Scaffold Materials is further studied across Composite Scaffold Materials, Nano-Scaffold Materials, Natural Biological Scaffold Materials, and Synthetic Biodegradable Polymer Scaffold Materials. The Equipment is further studied across Bioreactors, Cell Culture Chambers, and Image & Flow Cytometers.
• Based on Application, market is studied across Cardiovascular Applications, Dental & Craniofacial Applications, Drug Testing & Development, Orthopedic Applications, Regenerative Medicine, and Wound Healing.
• Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Potential need for tissue engineering procedures in treating irreversible damage of tissues
    • 5.1.1.2. Need for effective regenerative treatments owing to a rise in kidney and lifestyle related disorders
    • 5.1.1.3. Growing use of biogenic nanoparticles for advanced tissue engineering applications
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of suitable biomaterials and techniques for capturing appropriate physiological architectures
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in the field of 3D tissue engineering
    • 5.1.3.2. Surging government support for tissue engineering research projects
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent government regulations associated with tissue engineering
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Tissue Engineering Market, by Product

• 6.1. Introduction
• 6.2. Biomaterials
  • 6.2.1. Cell Sources
  • 6.2.2. Growth Factors & Bioactive Molecules
  • 6.2.3. Scaffold Materials
    • 6.2.3.1. Composite Scaffold Materials
    • 6.2.3.2. Nano-Scaffold Materials
    • 6.2.3.3. Natural Biological Scaffold Materials
    • 6.2.3.4. Synthetic Biodegradable Polymer Scaffold Materials
• 6.3. Equipment
  • 6.3.1. Bioreactors
  • 6.3.2. Cell Culture Chambers
  • 6.3.3. Image & Flow Cytometers
• 6.4. Services

7. Tissue Engineering Market, by Application

• 7.1. Introduction
• 7.2. Cardiovascular Applications
• 7.3. Dental & Craniofacial Applications
• 7.4. Drug Testing & Development
• 7.5. Orthopedic Applications
• 7.6. Regenerative Medicine
• 7.7. Wound Healing

8. Tissue Engineering Market, by End-User

• 8.1. Introduction
• 8.2. Academic & Government Research Institutes
• 8.3. Biotechnology & Pharmaceutical Companies
• 8.4. Contract Research Organizations

9. Americas Tissue Engineering Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Tissue Engineering Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Tissue Engineering Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. 3D BioFibR Enters the Bioprinting and 3D Cell Culture Market with the Launch of Two CollaFibR Tissue Engineering Products
  • 12.3.2. Essent Biologics Launches Revolutionary Human Native Tissue-Derived Type I Collagen
  • 12.3.3. BioMed X Extends Research Collaboration ith AbbVie On Immunology And Tissue Engineering
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Aspect Biosystems Ltd.
• 3. B. Braun SE
• 4. Baxter International Inc.
• 5. Bayer AG
• 6. Becton, Dickinson and Company
• 7. Cook Group Incorporated
• 8. Corning Incorporated
• 9. CTIBiotech
• 10. Frequency Therapeutics
• 11. Gel4Med
• 12. General Electric Company
• 13. Humacyte, Inc.
• 14. Integra LifeSciences Corporation
• 15. Johnson & Johnson Services, Inc.
• 16. Medtronic PLC
• 17. Merck KGaA
• 18. Miromatrix Medical, Inc.
• 19. Modern Meadow
• 20. Novartis AG
• 21. Organogenesis Inc.
• 22. Organovo Holdings, Inc.
• 23. Pfizer Inc.
• 24. Prellis Biologics
• 25. ReproCell Inc.
• 26. Smith & Nephew PLC
• 27. Stryker Corporation
• 28. Tissue Regeneration Systems Inc.
• 29. Vericel Corporation
• 30. Zimmer Biomet Holdings, Inc.